glp-1 usage by country Agonists Weight Loss Drugs Market Report, 2025-2030 Market Overview: GLP-1 Agonists and

(2021-2032) Chapter 2: Detailed analysis of Oral GLP-1 Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc

(2022) 8:e09394

Baggio et al., GLP-1 could rapidly control glucose homeostasis after food intake, because GLP-1 receptors are located in the intestine, portal vein, pancreas, and brain, and also GLP-1 induces vagal afferent neurons innervated into gut (Iwasaki et al., One study showed that GLP-1R antagonist's administration damages glucose tolerance and aggravates insulin resistance (Vahl et al., 2007)

3.1 Shortacting GLP1 receptor agonists 3.1.1 Beinaglutide BN is a recombinant human GLP-1(7-36) acid, obtained by genetic engineering technology, and the amino acid sequence of its active component is the same as that of GLP-1 in the human body